Sandoz Group Ltd ( (CH:SDZ) ) has provided an announcement.
At its Annual General Meeting, Sandoz Group Ltd announced that shareholders approved all proposals by the Board of Directors, including the re-election of Gilbert Ghostine as Chairman and a dividend of CHF 0.60 per share. The meeting also endorsed changes to the Articles of Incorporation to optimize the company’s capital structure, reflecting Sandoz’s commitment to strengthening its leadership and creating long-term value. These decisions are expected to enhance Sandoz’s operational efficiency and support its strategic goals in the healthcare industry.
More about Sandoz Group Ltd
Sandoz is a global leader in generic and biosimilar medicines, headquartered in Basel, Switzerland. The company focuses on pioneering access for patients and offers a portfolio of approximately 1,300 products, addressing a wide range of diseases. With a history of significant breakthroughs, Sandoz recorded net sales of USD 10.4 billion in 2024.
YTD Price Performance: -1.92%
Average Trading Volume: 3,609
Technical Sentiment Signal: Buy
Current Market Cap: $17.61B
Learn more about SDZ stock on TipRanks’ Stock Analysis page.